Valuation

Today’s academics are far more IP savvy, Imperial tech transfer head states

“We have a much more knowledgeable, skilled and entrepreneurial client base these days,” says Andrew Tingey

Today’s academics are far more IP savvy, Imperial tech transfer head states
A patent's journey from <em>IAM</em> Market to <em>Facebook v BlackBerry</em>
7 Jul 2020

A patent's journey from IAM Market to Facebook v BlackBerry

Analysis shows that assets listed on the platform sell at a higher rate than average, while they are also litigated more often

Unified’s $3bn PTAB report will make eyes roll - but dismiss it at your peril
26 Jun 2020

Unified’s $3bn PTAB report will make eyes roll - but dismiss it at your peril

Study claims that Board has led to an increase in business activity in the US and looks set to influence policy discussions

Latest

View all
24 Jun 2020

Top patent-owning companies enjoyed a May stock price surge, research reveals

The IAM/ktMINE US Patent Elite share tracker shows that a composite of the publicly-quoted companies in the rankings out-performed the NASDAQ, the Tokyo Stock Exchange and Germany's Dax Index Read more

24 Jun 2020

Japan government study group endorses ‘license-to-all’ SEP policy and ‘top-down’ FRAND rates

Attorneys and academics convened by Ministry of Economy Trade and Industry weigh in on key debates in the wireless licensing space Read more

23 Jun 2020

Big Pharma facing shortage of late-stage assets as M&A dries up

Pandemic has thrown a spanner in the works for large life sciences companies, which have fewer phase three novel drugs than at any point in the last decade Read more

18 Jun 2020

Takeda offloads yet more “non-core” assets with other deals likely to follow

The Japanese big pharma continues to divest drug rights to pay down its debt and fund desperately needed innovation Read more

News

View all
26 May 2020

WHO covid-19 IP pool launches this week without strong pharma support

Open and global sharing of patents, data and know-how is seen as a step too far by many life sciences innovators Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

16 May 2020

IP is here to stay, but everything is going to change

As IAM celebrates its 100th issue, a look back at how it all began, a fast forward to the future and a massive thank-you Read more

2 May 2020

It’s a downturn Jim, but not as IP owners know it

Patent rights may fare well in a recession but this is a global market unlike any other we have seen before Read more

Analysis

View all
15 Jun 2020

The University of California builds its patent portfolio, but not its royalty returns

The world-renowned school has seen its licensing income stall and that could force it to take a more aggressive line in securing ROI Read more

12 Jun 2020

Royalty Pharma’s $2 billion IPO target shows importance of patent monetisation in life sciences

The company’s public offering comes after years of growth and demonstrates the changing dynamics of an industry in which smaller R&D entities are becoming increasingly significant players Read more

10 Jun 2020

Fortress shells out $44 million for Finjan, keeps senior management led by Phil Hartstein in place

Eran Zur and his team add a portfolio of patents to their portfolio which have survived multiple attacks at the PTAB and read on a technology area of growing importance Read more

4 Jun 2020

Oppo buys SEP applications from Korean research entity, gearing up for the future of streaming

“We want to prepare for next generation of video codec as early as possible” an Oppo executive tells IAM Read more

Insights

View all
8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more

1 Oct 2017

A round-up of IP-related quotes, observations and opinions from the recent past …

A round-up of IP-related quotes, observations and opinions from the recent past …

Read more

30 Sep 2016

McRO gives hope to US patent owners, but Section 101 uncertainty remains

After two years of uncertainty and no little gloom, a recent Federal Circuit decision may just herald the long-awaited swing-back in the pendulum that software patent owners in the United States have been waiting for. Some, though, still believe that Congress must bite the bullet and take a look at Section 101 Read more

1 Aug 2016

Brexit leaves the UPC in limbo – and that’s no bad thing

The UK vote to leave the European Union may have surprised and disappointed many in the IP community, but a rush to bypass the decision and implement the unitary patent package would be a mistake

Read more

Find an expert

Bruce D Sunstein
Patent Attorney
Boston MA, United States
Sunstein LLP